View all veterinary jobs
VetNurse.co.uk publishes a curated feed of veterinary nursing news for registered veterinary nurses (RVNs), students (SVNs) and veterinary nursing assistants, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest or professional significance — filtering out noise so busy veterinary nurses can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, referral and specialist settings, with a focus on issues affecting veterinary nurses in clinical and professional roles.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetNurse news by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The winning images were selected from nine finalists, shortlisted from hundreds of entries that were taken by vets, both in their professional and private lives.
And the winners are ...
Sophie said: “I was very surprised to win with my photo of a newborn calf standing next to me during the closing phases of surgery.
"I'm not that slow at suturing up, it’s just the calf was very alert and standing before I finished!
"For me this photo encapsulates the best parts of farm vetting: prompt decisions, safe handling, great outcomes, teamwork.
"I’m very proud to be a farm vet and exceptionally pleased this photo will be seen by current farm vets and hopefully will inspire future farm vets from all walks of life to pursue a veterinary career.”
Katherine, who is a third year Veterinary Medicine student at the Royal Veterinary College, said: “I'm absolutely delighted to have my photograph selected as the winner of the category, especially against such impressive entries.
"I was on a morning visit to a game reserve with a local vet in South Africa, when the sunrise highlighted the small oxpeckers on the backs of the giraffes, frantically flying to and fro.
"With the giraffe curiously watching us, I managed to capture the moment all three birds landed on its back, creating the image representing all creatures great and small.”
Sam Price said: "I took the image of my dog, Winnie, while on a campervan trip on the north coast of Ireland.
She loves nothing more than a beach day as you can see so I felt this was a fitting photo for the brief.
Thankfully there was a rare bout of sunshine on the day which made for some nice lighting and Winnie is pretty photogenic, which always helps!"
BVA President Malcolm Morley said: “The winning images stood out to us for many reasons, but we particularly liked how each one captured the essence of the category it was entered into; Sophie’s image of a c-section on a cow was so touching and really demonstrates the daily life of many of our valued farm vets; Katherine Edmondson’s photograph of the giraffe and red-billed oxpeckers was stunning but also truly embodied the All creatures great and small element; while Sam Price’s photo of Winnie the dog literally jumping for joy stole our hearts and genuinely made us all break out in smiles.
“Congratulations to all the winners, and also a huge well done to all the finalists as well, it was a really tough decision but you should be proud of the incredible photographs you entered and your talents.”
Support for those studying to get the qualification includes access to an internal mentor, regular contact with Linnaeus’s nursing central support team, a training agreement covering things like additional CPD allowances, study time and networking opportunities specific to the candidate’s specialism.
Linnaeus also runs an internal VTS networking group to support both candidates and holders.
For VTS holders, Linnaeus now offers an enriched CPD package to support their re-certification process, which takes place every five years.
This includes an enhanced CPD budget and time allowance for attendance at international specialist conferences.
Holders are also invited to interprofessional discipline-specific away days and offered membership to a specialist organisation.
Vicky Ford-Fennah, Professional Development Manager at Linnaeus and a VTS holder in anaesthesia and analgesia (pictured), said: “Achieving the VTS status requires hard work and determination.
"This new process will provide our nurses with the support to set them up for success. It also recognises the different requirements of our VTS holders to maintain their status.
“Not only do our VTS candidates and holders improve their own skills; our education and networking opportunities enable them to share knowledge and become fantastic role models to other nurses wanting to progress their careers.
Sophie McMurrough is Nurse Team Leader in internal medicine at Northwest Veterinary Specialists in Runcorn and a VTS holder in Small Animal Internal Medicine.
She said: “Becoming a VTS holder has opened so many windows of opportunity for me. I have been able to master advanced clinical skills, teach my peers and share my knowledge through writing and speaking. I would encourage anyone with a passion for a specialist area to pursue the VTS.
The service will be run by Dr Eloise Quince BVetMed CertAVP(SAM-F) PgCertVPS MANZCVS MRCVS and Dr Kate Allgood BVetMed CertAVP(SAM) MRCVS.
The practice says radioactive iodine therapy is the treatment of choice for hyperthyroid cats as it provides a permanent cure in up to 95% of cases.
It is administered by an iodine injection under the skin in a specialised unit by a trained vet and nurse.
The practice says a benefit of RI is that it treats ‘ectopic tissue’ that may be present outside of the thyroid gland, for example in the chest, which is not treated by surgical methods of thyroid removal.
Normal thyroid tissue is also spared, so that there is normal thyroid function post-treatment.
Though some blood tests need to be taken post-treatment, there is no need for ongoing blood samples and the monitoring of the thyroid function once successful treatment has occurred.
Elissa Norman, Clinical Director, who initially developed the idea for the iodine unit said: “The iodine unit first started as a scribble on a piece of paper and a dream of our team back in 2017 and it has taken a huge amount of dedication and effort from a large team of people to get to the point of opening in 2023.
"Radioactive iodine offers a lifetime cure for our hyperthyroid cats and we are delighted to be able to bring this service to the cats of East Anglia.”
To refer a cat patient, vets should email iodine@veterinary-hospital.co.uk.
DogStem has been shown to be effective, reducing pain and lameness and improving mobility and quality of life for three months to over twelve months following a single injection1,2.
In a prospective, randomised, double-blinded, placebo-controlled trial of DogStem, results showed that2:
TVM highlights how DogStem simplifies the process and reduces the cost of using stem cell therapy in practice because unlike previous therapies, it does not require require a surgical harvesting procedure to be carried out under general anaesthetic.
Helen Harrison, DogStem Technical Vet and Product Manager said: "Osteoarthritis is one of the most common diseases seen in veterinary practices and is challenging to manage.
"Conventional medical treatments typically address the symptoms rather than the underlying pathological processes.
"At the same time, local treatment options that slow progression of osteoarthritis have been limited and surgical interventions aren’t always possible or may be unrewarding.
"We’re delighted to be able to offer vets DogStem®, a stem cell product with a strong evidence base across numerous mobility and quality of life parameters.’
DogStem can be ordered from NVS, or direct from: www.dogstem.co.uk
References
The research is being conducted by Sarah Mansell under the supervision of Dr. Malgorzata Behnke. They say this parasite hasn't been studied in depth in the UK since the 1970's, because the symptoms can be controlled by routine worming measures. However, as the industry moves away from routine worming as a measure of reducing the risk of parasites developing resistances to treatments, a condition such as this which is now considered to be quite rare in the UK can start to re-emerge.
Sarah is asking vets to fill out a short questionnaire to assess awareness of Onchocerca Cervicalis in veterinary practices. The survey includes specific questions about the parasite as well as questions about cases of unresponsive skin conditions because a similarity in symptoms can lead to misdiagnoses that could, in fact, turn out to be Onchocerca Cervicalis.
Sarah said: "Hopefully the findings will raise awareness of this problem and help shape future research in this area."
She added: "I want to get vets thinking about this issue much more than perhaps they are at the moment."
To take part in the survey, visit: https://harper-adams.onlinesurveys.ac.uk/assessing-the-awareness-of-onchocerca-cervicalis-amongst-e-2
Apovomin is effective after a single injection, with results in two to fifteen minutes.
Apovomin has the active substance apomorphine hydrochloride hemihydrate 3 mg (equivalent to apomorphine 2.56 mg). It is being marketed in 5 ml vials. It has a three-year shelf life and lasts for up to 28 days once broached.
Dechra Brand Manager Claire Morgan said: “Unfortunately there are many everyday substances that are toxic to dogs once ingested and time is of the essence when dogs have swallowed something that is poisonous to them.
“It is vital that veterinary professionals have access to a safe and effective treatment like Apovomin that they know they can rely on when dealing with cases like this.
“Apovomin offers a cost effective and successful treatment for accidental poisoning that will be an important tool for veterinary professionals in day-to-day practice.”
For more information visit www.dechra.co.uk.
The company says that despite the development of alternatives to natural bone grafting, such as allografts and synthetic products, autologous bone graft is still considered the standard. However, it has a number of disadvantages, such as donor site morbidities and lameness, limited availability of graft volume (particularly in small size pets) and additional surgical time.
Biocera-Vet is a new bone substitute indicated in surgical procedures where bone grafting is necessary, such as arthrodesis, complex fractures, corrective osteotomy used in correction of limb deformities or as add-on to Tibial Tuberosity Advancement (TTA).
Biocera-Vet is an injectable synthetic self-hardening calcium-phosphate cement combining osteo-inductive, osteo-conductive and osteo-integrative properties designed to support a fast and strong consolidation.
TheraVet says Biocera-Vet also presents an excellent safety profile thanks to its biocompatibility, reduced comorbidities and superior ergonomics which save a significant amount of surgical time.
Dr Olivier Stiévenart, an orthopaedic veterinary surgeon at Surgivet in Belgium said: "Using Biocera-Vet has enabled us to optimise our patient care considerably, by reducing the operating time by at least 30 minutes. The use of an efficient and rapid bone substitute represents a real progress in terms of both operations and the animal’s quality of life".
Julie Schurgers, Chief Commercial Officer of TheraVet, said: "Biocera-Vet is a unique product on the veterinary bone substitute market, combining outstanding bone consolidation properties with an excellent safety profile and superior ergonomics. We are very excited today to announce its commercialisation on the market and are convinced that this innovative product will significantly improve the daily practices of veterinarians, for the well-being of patients and their owners."
The product is now available in Belgium, and will be rolled out in France and the Netherlands shortly, with the rest of Europe following later in 2021 / 2022.
For more information, visit: https://www.thera.vet/en/biocera-vet.
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
According to the study1, which looked at Chihuahuas treated in first opinion practice, ownership in the UK has increased over five-fold in the past decade from 1.0% of all puppies born in 2005 to 5.4% in 2016.
However, the study also found the breed was particularly susceptible to a number of health issues, including: dental disease (13.5%), obesity (5.9%) and retained baby teeth (5.7%).
Compared with other dogs, Chihuahuas were also more prone to aggression (4.2%), slipping kneecap (4.0%) and retained testicles (3.9%).
Other findings included:
Dan O’Neill, senior lecturer at the RVC and author of the paper, said: "Chihuahuas are an old breed but the recent craze for them can cause some real welfare issues for this tiny dog. There is increasing evidence that unscrupulous breeders and dealers both inside and outside the UK are cashing in on this trend by making a lot of money but with little regard for the welfare of these puppies and breeding bitches."
Camilla Pegram, VetCompass epidemiologist at the RVC and co-author of the paper said: "Dental disease and retained baby teeth should be recognised as important health concerns for Chihuahuas, with preventative care for dental disease a key topic for discussion between vets and owners. In addition, many of the common or predisposed disorders, such as dental disease, retained baby teeth, sliding kneecap and retained testicle(s), often require surgical intervention. The Chihuahua’s small size increases its anaesthetic risk. Obesity has many detrimental effects, including increased anaesthetic risk, and aggression makes them challenging patients and pets, therefore nutrition, lifestyle and behaviour are also key areas for veterinary-owner discussions."
The full paper is open access: https://doi.org/10.1186/s12917-020-2258-1.
Reference:
The College says the event is aimed at RVNs who are interested in upholding standards of veterinary nursing professional conduct and who would like to help the RCVS maintain public confidence in the veterinary nursing profession. Prospective applicants for these roles should ideally have a minimum of five years' experience in veterinary nurse practice.
Attendees will have the opportunity to chat to representatives of the committee, and the staff involved in handling cases that go to disciplinary hearings. There will also be a short presentation on the application process from Thewlis Graham Associates – the external agency handling the recruitment.
RCVS staff and DC members will present some anonymised VN DC / DC example cases to talk through in small informal groups, to help convey an idea of the work involved and the challenges one could expect to face when making decisions on allegations of serious professional misconduct or fitness to practise.
The overall programme will be run in the afternoon from 3pm – 5pm and repeated in the early evening from 6pm – 8pm, to suit differing diaries and travel times. Snacks and refreshments will be provided on the day, and the RCVS will reimburse reasonable travel expenses for attendees.
Places at the information day can be reserved by contacting Deborah Rowlanes, RCVS Events Manager, via D.Rowlanes@rcvs.org.uk or 020 7202 0773. The deadline for registering is Friday 21 February 2020.
Alternatively, if you can't attend on the day itself, but would like to speak to the RCVS Registrar and Director of Legal Services Eleanor Ferguson about the vacancies, you can contact Deborah to arrange a convenient time.
Prospective committee members will then have until 5pm GMT Monday 2 March to submit their applications. Applications can be submitted through the Thewlis Graham Associates website: www.thewlisgraham.com/assignment-briefings.
Anyone completing the BVRA Foundation Course will receive a joint BVRA/iPET Network Certificate of Achievement.
BVRA is also working on creating an Ofqual Regulated qualification in the sector, which will be available in the autumn 2023.
BVRA CEO, Kay Watson-Bray (pictured) said: “We have been listening to our members and their employers and identified the quality assurance that comes with regulation is a really important aspect of accredited CPD.
"This initiative will give veterinary receptionists the opportunity to gain an official qualification with transferable credits that they can use as a stepping stone to higher education and will provide a defined career path.”
The BVRA has also relaunched what was the Registered Veterinary Receptionist (RVR) as the new BVRA Associate Veterinary Receptionist (AVR).
Being an AVR gives BVRA members further membership benefits, training and status.
Kay added: “It’s an exciting time for veterinary receptionists who have previously had limited career path opportunities. BVRA is committed to provide the most up to date, relevant CPD created by industry experts.”
www.bvra.co.uk
To raise the funds, CVS put customer and staff collection boxes in its small animal first opinion practices and referral hospitals.
Staff also held a number of fundraising events – including sponsored walks and dog shows, as well as hosting Pet Blood Bank donation days.
The money raised from the partnership will help go towards funding Pet Blood Bank’s work.
Last year the charity sent over 5,000 units of blood to vets across the UK.
Pet Blood Bank provides training for vets and nurses, and donations also help the charity to keep the cost of blood products as low as possible, and provide them free to veterinary charities.
Deputy Chief Executive of CVS Group, Ben Jacklin, said: “Pet Blood Bank is a vital charity doing crucial work within our profession.
"There is no doubt that the level of funds raised is down to the tireless commitment shown by our colleagues up and down the country.
"I’d also like to recognise the role our clients have also made - as without them we would never have reached such a great total.”
Managing Director of Pet Blood Bank, Katrina Wilkinson said: “This generous donation from CVS Group has been incredible to receive.
"We are a small charity so need all the support we can get, and CVS has truly delivered."
CVS has recently announced its next charity partner as Guide Dogs for the Blind.
Skin diseases and palpable masses are a common presentation in guinea pigs brought for veterinary care2.
However, few studies have thus far looked at the prevalence of spontaneously arising diseases in pet guinea pigs.
"Lumpy bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology" retrospectively analysed 619 biopsy samples submitted for histopathology from pet guinea pigs that had presented with externally palpable masses.
The purpose was to determine the most common tissue origins of these masses and the most frequent pathological diagnoses, together with signalment data for the most commonly diagnosed lesions.
Of the 619 samples submitted from 493 animals, 54 (8.7%) had arisen from the mammary glands3 and 15 (2.4%) from the thyroid glands, with the remaining 550 (88.9%) involving the skin and subcutis, muscle (n = 1), salivary glands (n = 4), lips (n = 2), ears (n = 4) and peripheral lymph nodes (n = 23).
Forty-seven (7.6%) of the masses were diagnosed as inflammatory in nature, including dermatitis, panniculitis, lymphadenitis, cheilitis, myositis, sialoadenitis, abscess and chronic inflammation with osseous metaplasia.
Non-neoplastic, non-inflammatory lesions accounted for a further 31 (5.0%), namely cysts, hamartomas, hyperplastic lesions, polyps, ectopic bone formation and salivary gland steatosis.
The remainder of the samples were neoplastic in nature (541; 87.4%), with 99 masses classified as epithelial in origin, 347 as mesenchymal, 23 as round cell, five as melanocytic and eight as unclassified malignant neoplasms.
Of these, mesenchymal neoplasms were further subdivided into benign (288) and malignant (59).
Lipomas were the most common neoplasm diagnosed, accounting for 286 of all samples submitted.
Of all 619 samples included in the study, the eight most commonly diagnosed lesions were lipoma (46.2%), trichofolliculoma (12.3%), sarcoma (of various subtypes: 9.5%), inflammation (all sites 7.6%), lymphoma / leukaemia (3.4%), mammary carcinoma (4%), mammary adenoma (3.2%) and thyroid carcinoma (1.5%).
Overall these eight diagnoses accounted for 87.7% of all submissions from the externally palpable masses from the pet guinea pigs submitted for histopathology.
Melanie said: “Guinea pigs are an increasingly popular household pet.
"Skin diseases, including palpable masses, are a common reason for veterinary presentation. But few studies have been published to date that provide information for clinicians about these conditions.
“This study illustrates the importance of neoplasms of the skin and subcutis in pet guinea pigs, with over 87% of the cases analysed having one of eight diagnoses.
"While most of these neoplasms are benign, a substantial minority are malignant and identifying those lesions is especially important in treatment planning.
"Clinicians dealing with pet guinea pigs should also be aware that some externally palpable masses may arise from the thyroid or mammary glands rather than the skin or subcutis, and that male guinea pigs may also develop mammary lesions.”
The paper has been selected as ‘Editor’s Choice’ by the Journal of Comparative Pathology and will be free to access until September on Lumpy, bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology - ScienceDirect.
Miss Herdman faced three charges.
The first was that she indicated to a friend that she would supply diazepam and/or tramadol for use by their husband.
The second was that she supplied diazepam and/or tramadol and/or gabapentin.
The third was that she gave advice on the dosages of diazepam and/or tramadol and/or gabapentin.
Miss Herdman was not present at the hearing and was unrepresented, but the Committee determined that it was appropriate to proceed in her absence as she had been notified, was aware that the hearing was taking place and her absence was voluntary.
However, Miss Herdman had been in contact to indicate her pleas to the charges.
She admitted the intention to supply diazepam and/or tramadol and that she had provided advice on the dosages.
She also admitted that she had supplied diazepam but strongly denied that she had supplied tramadol and/or gabapentin.
Taking all the evidence into account (including messages sent by Miss Herdman and her admissions), the Committee found proven the charges in relation to the intent to supply and the advice on dosages.
The Committee also found proven the charge in relation to the supply of diazepam, but found not proved the charge relating to the supply of tramadol and gabapentin for several reasons, including the fact that the messages sent by Miss Herdman did not point unequivocally to her actually suppling each of the drugs to which she referred.
There was no suggestion that the diazepam was stolen from her place of work.
The Committee found that Miss Herdman’s actions had breached paragraphs 1.5 and 6.5 of the Code of Professional Conduct for Veterinary Nurses.
The committee judged that there were a number of aggravating features of Miss Herdman’s conduct, including that she was not qualified or authorised to prescribe medication to animals, let alone to human beings and that providing a controlled drug to a person who was already taking various painkilling medications was reckless.
The Committee also felt that a reasonable and informed member of the public would be very concerned to learn that a veterinary nurse had supplied a controlled drug to a friend for their personal use.
Regarding the sanction for Miss Herdman, Paul Morris, chairing the Veterinary Nursing Disciplinary Committee and speaking on its behalf, said: “Drawing all the material together, and considering the matter as a whole, the Committee had to impose a proportionate sanction for an isolated incident of serious professional misconduct which arose out of a misguided attempt to help a friend.
"The conduct in question was entirely out of keeping with Miss Herdman’s usual practice and there is no real risk that it will be repeated.
"However, this case was much too serious to take no further action and no useful purpose would be served by postponing a sanction.
“The Committee considered that a warning or reprimand would not be sufficient to satisfy the public interest as veterinary nurses are trusted by the public to deal with medication responsibly and failure to do constitutes a severe breach of trust.
“The Committee therefore considered a period of suspension sufficient to meet the public interest in maintaining the reputation of the profession and declaring and upholding proper standards of conduct for members of the profession.
“The Committee also considered whether a removal order would be appropriate but concluded it would be disproportionate and that such a step would remove from the profession an experienced, competent and valuable veterinary nurse for no discernible benefit.
“It was decided that Miss Herdman’s registration be suspended for a period of three months – a period which is sufficient to mark the gravity of the misconduct while taking into account the circumstances in which it arose.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
The day will be led by Sonya Miles, BVSc CertAVP (ZM), CertAqV, MRCVS, RCVS Recognised Advanced Practitioner in Zoological Medicine and WAVMA Certified Aquatic Species Veterinarian.
Lectures will look at techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques in a wide variety of exotic species.
Delegates will also be provided with lecture notes, a CPD certificate, refreshments and lunch, as well as goodie bags provided by sponsors Pinmoore Animal Laboratory Services Limited.
Sonya says the aim of the day is to dispel many myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
To book your place or for more information, email: info@justexotics.co.uk or book online at https://justexoticsevents.co.uk/dont-miss-out-on-our-latest-event
Phovia, which was launched in the UK last year, is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
Vetoquinol says that when used together they produce light of varying wavelengths that penetrates the skin to different depths, helping to control bacteria and reduce inflammation on the surface of the skin and stimulating regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
The authors of the Vetoquinol-funded study say that FLE has already been shown to support and accelerate natural skin healing, but this latest research shows that the benefits go beyond improvement in clinical signs.
The study looked at 35 dogs with a diverse range of skin conditions: 13 had interdigital furunculosis, 10 had deep pyoderma, 6 had wounds, 4 had pyotraumatic dermatitis, and 2 had perianal fistula on presentation.
Eight of 35 dogs were new cases, whereas the remaining 27 were undergoing recrudescence of a prior episode, including pyotraumatic dermatitis, wounds, deep pyoderma, interdigital furunculosis and perianal fistulae.
Thirty dogs (86%) achieved a clinical resolution: 18 with the Fluorescent Light Energy alone and 12 with the concomitant use of FLE and topical antiseptic shampoo.
Five dogs (14%) had a partial response and needed other therapies.
92% percent of owners attested to their pet’s enhanced quality of life, with 74% of dogs displaying at least a 50% improvement in owner-reported behaviour, mood, sleep and playing activities.
The study also reported a 46% reduction in caregiver burden.
Felicity Caddick, Technical Services Manager at Vetoquinol said: “Managing skin conditions often requires the long-term use of shampoos or topical therapies.
"Many owners find this aspect of pet ownership challenging, especially with larger dogs, or less cooperative animals.
"FLE can reduce or in some cases eliminate the need for topical therapies at home, not only simplifying the treatment process but also enhancing convenience and compliance.
"Sharing responsibility for administering ongoing treatment with their vet practice also removes some of the worry associated with their pet’s health.”
Vetoquinol also highlights that Phovia can offer vets a drug-free management option for skin disorders that aligns with the principles of antibiotic stewardship.
Reference
The webinar will allow veterinary teams to learn from three expert speakers how they can make small practical changes to have positive impacts in their own settings.
Helen Ballantyne, Chair of the UK One Health Coordination Group (UKOHCG) and both a human and animal health nurse, will provide a ‘human’ view of One Health and the strategies in the NHS.
She will highlight areas of excellent practice she has experienced, and from a One Health angle where the veterinary profession could learn from the NHS, and vice versa.
Fergus Allerton MRCVS, an Internal Medicine Specialist and lead on antimicrobial resistance (AMR) at Linnaeus will talk about, amongst other things, the optimal use of antimicrobials for infection control.
In collaboration with the NHS, he launched Veterinary Antibiotic Amnesty activity which saw a 19% reduction of antimicrobial use across the Linnaeus veterinary group.
Fergus will also talk about the PROTECT ME guidelines on the responsible use of antibacterials, such as for surgical antibiotic prophylaxis.
Simon Doherty, past-president of the British Veterinary Association and one of two BVA representatives at the Federation of Veterinarians in Europe, will focus on the history of One Health and One Agriculture; highlighting how improved communication and collaboration at the intersection of people, animals and the environment can drive productivity and sustainability in food production.
Simon will also share some of Vet Sustain’s farm animal resources and how the principles can be applied.
To register, visit: https://horiba.link/one-health-webinar
The 'Lifelong Ear Partnership' resources, which were developed in conjunction with a panel of vets, are designed to help practice teams improve their owner communication and achieve owner buy-in about otitis.
To that end, Dechra has developed various owner communication tools for use in practice or to refer owners to after the consultation.
They include an owner website: www.ear-inflammation.co.uk and a postcard with QR code links to educational videos which cover clinical recommendations, treatment options and the importance of revisits.
There is also a brochure for owners and an online 4D ear model: www.4d-earmodel.com, which demonstrates a healthy ear and an ear with mild, moderate or severe otitis.
Finally, Dechra has also launched an ear cytology webinar series on Dechra Academy: www.dechra.co.uk/academy.
The course consists of tips for everything from greeting the patient to performing and interpreting cytology slides.
www.dechra.co.uk/otitis-externa.
New statistics from the Voice of the Veterinary Profession Spring 2022 survey showed that while veterinary work is often seen as a vocation, 77% of vets list pay among their top five priorities when choosing a job.
Other deciding factors include geographical location (74%), area of practice (62%), low staff turnover (45%) and structured career progression (28%).
However only 42% of vets who responded to the survey considered their pay and benefits to be either ‘good’, ‘very good’, or ‘excellent’.
BVA President Malcolm Morley, said: “Fair, transparent and equal pay is one of the keystones of good veterinary workplaces.
"Whether you’re an employee, a manager or an employer, it’s vital that everyone feels confident that their workplace approaches pay in a clear and consistent way.
"This isn’t about paying everyone more; it’s about using objective criteria and transparent pay scales to ensure the whole team understands how decisions about reward and recognition are made and what they can do to access higher pay.”
The new resource, created for BVA members as part of its Good Veterinary Workplaces campaign, includes information for veterinary employers on the benefits a clear pay structure can bring for the whole team.
It demonstrates the positive impact transparency around reward and recognition can have on employee fulfilment and retention, and outlines the legal requirements of employers to ensure that pay is equitable.
It also offers tips for employees and managers for approaching conversations about pay and emphasises the importance of considering ‘total reward’ during these conversations.
Total reward is the entire sum of a job’s offering including, but not limited to, salary, commission structure, benefits package, CPD, work/life balance, promotion opportunities, travel expenses, accommodation, and so on.
Malcolm added: “We know that pay can be a fraught, and even somewhat taboo, subject but it is one that we all have a responsibility to tackle if we want to ensure that veterinary professionals are fairly rewarded for their work.
"We hope that this new guide will support all our members and equip them with the knowledge required to ensure they can confidently navigate conversations about pay.”
https://www.bva.co.uk/talking-pay
The Linnaeus OAPC initiative was launched in 2021 and originally allocated £30K for 2022.
However, that figure was doubled after the company received a growing number of high quality submissions.
33 papers were accepted for funding in 2022, of which 24 have so far been published and the remainder are undergoing peer review.
The authors comprise clinicians, specialists, residents and interns across nine referral and primary care sites within the group.
The OAPC was introduced by Professor Luisa De Risio, Clinical Research & Excellence Director at Linnaeus (pictured right).
She said: “By making clinical research open access, we can ensure it makes the widest possible impact – while also supporting the author’s profile and career development.
"We are continuing to offer OAPC funding to our associates in 2023 and look forward to seeing the fantastic research published as a result.”
To ask Shelly a question, first read her article here: https://www.veterinary-practice.com/article/pain-management-for-veterinary-nurses
Then join the VetNurse Clinical Article Club here: https://www.vetnurse.co.uk/001/vetnurse-clinical-article-club
Then post your question or discuss the article in this thread: https://www.vetnurse.co.uk/001/vetnurse-clinical-article-club/f/clinical-article-club-discussions/32396/pain-management-for-veterinary-nurses
£50 for the post which provokes the most discussion by the end of the week!
Remember, all time spent reading or participating in Clinical Article Club discussions can be claimed towards your annual CPD requirement: Press 'Claim CPD' at the top of the discussion thread.
32% said they find dog care to be too restrictive
29% said it would be too difficult to go on holiday
24% said they don’t want to walk the dog every day and 25% that having a dog is too expensive.
41% of those who said they regret getting a dog bought it during lockdown.
Zoetis has announced a supply problem with Equip Artervac, its vaccine against equine viral arteritis
The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end of September 2023.
Zoetis says it has been working with relevant organisations to implement a plan to mitigate the impact on breeders.
The Thoroughbred Breeders Association has published advice for a blood sampling scheme at: https://www.rossdales.com/news-events/tba-members-equine-vaccine-advice-regarding-disruption-to-supply-of-equip-artervac, but Zoetis highlights that the advice requires action two weeks after the most recent EVA vaccination.
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0345 300 8034
The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.
Membra is a transparent, water-resistant, non-toxic, biodegradable bandage replacement consisting of a hydrogel polymer which can be applied to open wounds.
It is initially applied as a liquid and quickly gels into a thin, flexible layer over the site.
The initial liquid phase of Membra allows it to cover open and irregular spaces as well as suture lines and it dries in minutes to form a barrier that covers and protects the incision site or wound.
Being transparent, Membra allows the wound to be seen by the veterinary team and pet owners.
Membra lasts for up to 14 days and naturally biodegrades over time.
Animus says that Membra lowers the risk of infection or dehiscence.
The company also says that hydrogel polymer has been shown to replace the need for adhesive bandaging on suture lines following major TPLO surgery.
A study concluded that the polymer did not appear to raise the prevalence of incisional complications after TPLO surgery and lasts for 14 days, rather than 24-48 hours with traditional bandaging1.
Nick Butcher MRCVS, owner of Animus Surgical in the UK, said: “Regular bandaging of open wounds can be costly, time-consuming and stressful for owners and their pets, requiring frequent visits to the practice.
"The bandaging of some open wounds can be impossible because of the location of the lesion or the affected species (e.g. exotic or aquatic animals) and more aggressive or nervous patients may require sedation.
"Used bandages also add to the volume of clinical waste generated by the practice which requires incineration
“We are therefore delighted to launch Membra to veterinary teams in the UK.
"It has been very successful in the U.S. and we already have a number of UK vets using the product as Membra can positively affect the outcome of open wound management across a range of species, without the need for regular bandage changes.”
To find out how to apply Membra, a range of YouTube videos are available showing a selection of case examples: https://youtube.com/@sutureseal5917.
www.animussurgical.com.